← golden set
HON
HONEYWELL INTERNATIONAL INCIndustrialsanswer key
| field | SEC value | XBRL concept | printed on |
|---|---|---|---|
| Total revenue | $37.4B | RevenueFromContractWithCustomerExcludingAssessedTax | Net sales |
| Operating income | $8.1B | OperatingIncomeLoss | not printed on the statement, not scored |
| Net income attributable to the company | $4.7B | NetIncomeLoss | Net income attributable to Honeywell |
| Diluted EPS | $7.36 | EarningsPerShareDiluted | Earnings per share of common stock from continuing operations-assuming dilution · Total earnings per share of common stock-assuming dilution |
| Cash and cash equivalents | $12.5B | CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents |
| Total assets | $73.7B | Assets | Total assets · Total liabilities, redeemable noncontrolling interest and shareowners’ equity |
| Total liabilities | - | not reported | not in this filing's XBRL |
| Total shareholders' equity attributable to the company | $13.9B | StockholdersEquity | Total Honeywell shareowners’ equity |
| Net cash from operating activities | $6.4B | NetCashProvidedByUsedInOperatingActivities | Net cash provided by operating activities |
| Net cash from investing activities | -$2.7B | NetCashProvidedByUsedInInvestingActivities | Net cash used for investing activities |
| Net cash from financing activities | -$2.0B | NetCashProvidedByUsedInFinancingActivities | Net cash (used for) provided by financing activities |
Income statement
table #113 · score 51.8 vs 33 runner-up · in millions| Years Ended December 31, | |||
| 2025 | 2024 | 2023 | |
| (Dollars in millions,except per share amounts) | |||
| Product sales | 24,515 | 22,841 | 22,345 |
| Service sales | 12,927 | 11,876 | 10,664 |
| Net sales | 37,442 | 34,717 | 33,009 |
| Costs, expenses and other | |||
| Cost of products sold | 16,153 | 15,017 | 14,836 |
| Cost of services sold | 7,460 | 6,343 | 5,801 |
| Total Cost of products and services sold | 23,613 | 21,360 | 20,637 |
| Research and development expenses | 1,812 | 1,454 | 1,375 |
| Selling, general and administrative expenses | 5,450 | 5,235 | 4,887 |
| Impairment of goodwill | 724 | - | - |
| Impairment of assets held for sale | 270 | 219 | - |
| Other (income) expense | (1,247) | (843) | (830) |
| Interest and other financial charges | 1,344 | 1,048 | 749 |
| Total costs, expenses and other | 31,966 | 28,473 | 26,818 |
| Income from continuing operations before taxes | 5,476 | 6,244 | 6,191 |
| Tax expense | 1,008 | 1,249 | 1,262 |
| Net income from continuing operations | 4,468 | 4,995 | 4,929 |
| Net income from discontinued operations | 304 | 745 | 743 |
| Net income | 4,772 | 5,740 | 5,672 |
| Less: Net income attributable to noncontrolling interest | 43 | 35 | 14 |
| Net income attributable to Honeywell | 4,729 | 5,705 | 5,658 |
| Earnings per share of common stock-basic: | |||
| Earnings per share of common stock from continuing operations-basic | 6.98 | 7.63 | 7.41 |
| Earnings per share of common stock from discontinued operations-basic | 0.42 | 1.13 | 1.12 |
| Total earnings per share of common stock-basic | 7.40 | 8.76 | 8.53 |
| Earnings per share of common stock-assuming dilution: | |||
| Earnings per share of common stock from continuing operations-assuming dilution | 6.94 | 7.58 | 7.36 |
| Earnings per share of common stock from discontinued operations-assuming dilution | 0.42 | 1.13 | 1.11 |
| Total earnings per share of common stock-assuming dilution | 7.36 | 8.71 | 8.47 |
Balance sheet
table #117 · score 55 vs 24.8 runner-up · in millions| December 31, | ||
| 2025 | 2024 | |
| (Dollars in millions) | ||
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | 12,487 | 9,906 |
| Short-term investments | 443 | 386 |
| Accounts receivable, less allowances of $202 and $307, respectively | 7,621 | 7,247 |
| Inventories | 6,162 | 5,884 |
| Assets held for sale | 2,492 | 1,365 |
| Other current assets | 1,182 | 1,259 |
| Current assets of discontinued operations | - | 1,861 |
| Total current assets | 30,387 | 27,908 |
| Investments and long-term receivables | 1,404 | 1,230 |
| Property, plant and equipment-net | 4,629 | 4,457 |
| Goodwill | 21,079 | 21,019 |
| Other intangible assets-net | 6,736 | 6,621 |
| Deferred income taxes | 199 | 235 |
| Other assets | 9,247 | 10,556 |
| Assets of discontinued operations | - | 3,170 |
| Total assets | 73,681 | 75,196 |
| LIABILITIES | ||
| Current liabilities | ||
| Accounts payable | 6,315 | 6,109 |
| Commercial paper and other short-term borrowings | 5,893 | 4,273 |
| Current maturities of long-term debt | 1,546 | 1,325 |
| Accrued liabilities | 8,462 | 8,055 |
| Current liabilities of discontinued operations | - | 1,086 |
| Liabilities held for sale | 1,198 | 408 |
| Total current liabilities | 23,414 | 21,256 |
| Long-term debt | 27,141 | 25,440 |
| Deferred income taxes | 1,577 | 1,581 |
| Postretirement benefit obligations other than pensions | 111 | 112 |
| Asbestos-related liabilities | - | 1,325 |
| Other liabilities | 6,408 | 5,581 |
| Liabilities of discontinued operations | - | 740 |
| Redeemable noncontrolling interest | - | 7 |
| SHAREOWNERS’ EQUITY | ||
| Capital-common stock issued | 958 | 958 |
| -additional paid-in capital | 10,157 | 9,695 |
| Common stock held in treasury, at cost | (43,029) | (39,378) |
| Accumulated other comprehensive loss | (5,146) | (3,491) |
| Retained earnings | 50,964 | 50,835 |
| Total Honeywell shareowners’ equity | 13,904 | 18,619 |
| Noncontrolling interest | 1,126 | 535 |
| Total shareowners’ equity | 15,030 | 19,154 |
| Total liabilities, redeemable noncontrolling interest and shareowners’ equity | 73,681 | 75,196 |
Cash flow statement
table #119 · score 55 vs 10 runner-up · in millions| Years Ended December 31, | |||
| 2025 | 2024 | 2023 | |
| (Dollars in millions) | |||
| Cash flows from operating activities | |||
| Net income | 4,772 | 5,740 | 5,672 |
| Less: Net income from discontinued operations | 304 | 745 | 743 |
| Net income from continuing operations | 4,468 | 4,995 | 4,929 |
| Adjustments to reconcile net income from continuing operations to net cash provided by operating activities | |||
| Depreciation | 546 | 493 | 490 |
| Amortization | 842 | 659 | 514 |
| Loss (gain) on sale of non-strategic businesses and assets | 18 | 1 | (5) |
| Impairment of goodwill | 724 | - | - |
| Impairment of assets held for sale | 270 | 219 | - |
| Repositioning and other (gains) charges | (167) | 239 | 844 |
| Net payments for repositioning and other charges | (378) | (470) | (445) |
| NARCO Buyout payment | - | - | (1,325) |
| Resideo indemnification and reimbursement agreement termination payment | 1,590 | - | - |
| Asbestos liabilities divestiture payment | (1,428) | - | - |
| Pension and other postretirement income | (396) | (477) | (408) |
| Pension and other postretirement benefit payments | (20) | (32) | (35) |
| Stock compensation expense | 196 | 189 | 197 |
| Deferred income taxes | 18 | (229) | 189 |
| Other | 144 | (191) | (534) |
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures | |||
| Accounts receivable | (825) | (129) | 67 |
| Inventories | (636) | (286) | (549) |
| Other current assets | (233) | (111) | 224 |
| Accounts payable | 724 | 78 | 444 |
| Accrued liabilities | 1,325 | 233 | 270 |
| Income taxes | (707) | (69) | (408) |
| Net cash provided by operating activities from continuing operations | 6,075 | 5,112 | 4,459 |
| Net cash provided by operating activities from discontinued operations | 333 | 985 | 881 |
| Net cash provided by operating activities | 6,408 | 6,097 | 5,340 |
| Cash flows from investing activities | |||
| Capital expenditures | (986) | (871) | (741) |
| Proceeds from disposals of property, plant and equipment | 31 | - | 43 |
| Increase in investments | (1,503) | (1,077) | (560) |
| Decrease in investments | 1,469 | 870 | 971 |
| (Payments) receipts from settlements of derivative contracts | (399) | 94 | 6 |
| Cash paid for acquisitions, net of cash acquired | (2,211) | (8,880) | (718) |
| Proceeds from sales of businesses, net of fees paid | 1,157 | - | 4 |
| Net cash used for investing activities from continuing operations | (2,442) | (9,864) | (995) |
| Net cash used for investing activities from discontinued operations | (269) | (293) | (298) |
| Net cash used for investing activities | (2,711) | (10,157) | (1,293) |
| Years Ended December 31, | |||
| 2025 | 2024 | 2023 | |
| (Dollars in millions) | |||
| Cash flows from financing activities | |||
| Proceeds from issuance of commercial paper and other short-term borrowings | 24,297 | 13,838 | 12,991 |
| Payments of commercial paper and other short-term borrowings | (22,815) | (11,578) | (13,663) |
| Proceeds from issuance of common stock | 237 | 537 | 196 |
| Proceeds from issuance of long-term debt | 4,035 | 10,408 | 2,986 |
| Payments of long-term debt | (2,909) | (1,812) | (1,731) |
| Repurchases of common stock | (3,804) | (1,655) | (3,715) |
| Cash dividends paid | (2,976) | (2,902) | (2,855) |
| Pre-separation funding | 1,962 | - | - |
| Spin-off cash | (449) | - | - |
| Other | 469 | 3 | 28 |
| Net cash (used for) provided by financing activities | (1,953) | 6,839 | (5,763) |
| Effect of foreign exchange rate changes on cash and cash equivalents | 176 | (137) | 14 |
| Net increase (decrease) in cash and cash equivalents | 1,920 | 2,642 | (1,702) |
| Cash and cash equivalents at beginning of period | 10,567 | 7,925 | 9,627 |
| Cash and cash equivalents at end of period | 12,487 | 10,567 | 7,925 |